Vimian Group’s Specialty Pharma segment Nextmune has acquired the veterinary allergy division,
“This acquisition significantly strengthens Nextmune’s competitive position in the
© Modular Finance, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
31.4 SEK | +3.46% | +3.63% | +6.08% |
02/05 | Transcript : Vimian Group AB, Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Vimian Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Vimian Group’s Specialty Pharma segment Nextmune has acquired the veterinary allergy division,
“This acquisition significantly strengthens Nextmune’s competitive position in the
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+6.08% | 1.45B | |
-8.62% | 6.64B | |
+24.75% | 3.7B | |
-1.53% | 3.12B | |
-15.13% | 1.37B | |
-25.63% | 1.24B | |
-7.42% | 1.21B | |
-10.84% | 1.17B | |
-.--% | 1.05B | |
-7.07% | 820M |